Total Payments
$28,539
2024 Payments
$172.43
Companies
23
Transactions
68
Medicare Patients
17,957
Medicare Billing
$8.2M
Payment Breakdown by Category
Other$24,896 (87.2%)
Gifts$1,809 (6.3%)
Food & Beverage$1,735 (6.1%)
Education$99.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $24,381 | 3 | 85.4% |
| Gift | $1,809 | 2 | 6.3% |
| Food and Beverage | $1,735 | 59 | 6.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $498.44 | 2 | 1.7% |
| Education | $99.00 | 1 | 0.3% |
| Honoraria | $16.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec USA, Inc. | $24,381 | 3 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $1,984 | 5 | $0 (2020) |
| Notal Vision, Inc. | $498.44 | 2 | $0 (2022) |
| Alimera Sciences, Inc. | $489.06 | 11 | $0 (2023) |
| Genentech USA, Inc. | $292.68 | 10 | $0 (2024) |
| ABBVIE INC. | $130.87 | 6 | $0 (2024) |
| NotalVision | $113.19 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $99.00 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $66.17 | 4 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $57.64 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172.43 | 8 | ABBVIE INC. ($72.29) |
| 2023 | $4,387 | 10 | Carl Zeiss Meditec USA, Inc. ($4,211) |
| 2022 | $8,432 | 14 | Carl Zeiss Meditec USA, Inc. ($7,609) |
| 2021 | $12,686 | 3 | Carl Zeiss Meditec USA, Inc. ($12,561) |
| 2020 | $1,843 | 3 | Carl Zeiss Meditec, Inc. ($1,789) |
| 2019 | $349.02 | 14 | Alimera Sciences, Inc. ($133.67) |
| 2018 | $116.09 | 6 | Mallinckrodt LLC ($38.17) |
| 2017 | $553.78 | 10 | Carl Zeiss Meditec, Inc. ($153.39) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/06/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: EYE CARE | ||||||
| 08/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Ophthalmology | ||||||
| 04/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: EYE CARE | ||||||
| 12/31/2023 | Carl Zeiss Meditec USA, Inc. | VISUCAM Fundus Cameras (Device) | Long term medical supply or device loan | In-kind items and services | $4,211.06 | General |
| Category: Fundus Camera | ||||||
| 08/18/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: EYE CARE | ||||||
| 08/15/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), VYZULTA | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Ophthalmology | ||||||
| 06/26/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Ophthalmology | ||||||
| 06/23/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 02/22/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/01/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/01/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/24/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 12/31/2022 | Carl Zeiss Meditec USA, Inc. | VISUCAM Fundus Cameras (Device) | Long term medical supply or device loan | In-kind items and services | $7,609.10 | General |
| Category: Fundus Camera | ||||||
| 10/28/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RETINA | ||||||
| 09/26/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/13/2022 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 09/07/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: RETINA | ||||||
| 08/17/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/09/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,680 | 8,990 | $7.1M | $1.7M |
| 2022 | 19 | 4,829 | 11,429 | $8.4M | $2.1M |
| 2021 | 20 | 4,602 | 11,092 | $5.8M | $2.0M |
| 2020 | 20 | 4,846 | 12,800 | $5.8M | $2.4M |
Total Patients
17,957
Total Services
44,311
Medicare Billing
$8.2M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 178 | 1,568 | $4.3M | $1.1M | 25.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 37 | 854 | $805,472 | $154,929 | 19.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 327 | 1,282 | $590,306 | $133,658 | 22.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 641 | 998 | $426,252 | $96,624 | 22.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 295 | 671 | $204,483 | $49,112 | 24.0% |
| 92134 | Imaging of retina | Office | 2023 | 603 | 1,489 | $204,060 | $47,561 | 23.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 120 | 354 | $70,600 | $26,089 | 37.0% |
| 92250 | Photography of the retina | Office | 2023 | 566 | 682 | $90,843 | $21,653 | 23.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 18 | 18 | $67,016 | $17,164 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 161 | $68,092 | $14,311 | 21.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 110 | 113 | $50,684 | $13,530 | 26.7% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 52 | 53 | $47,666 | $12,316 | 25.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 98 | 191 | $38,200 | $10,025 | 26.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 65 | 65 | $32,644 | $7,465 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $24,016 | $5,473 | 22.8% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 357 | 406 | $26,482 | $5,004 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $5,060 | $1,211 | 23.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 24 | 24 | $1,958 | $449.82 | 23.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 222 | 1,800 | $4.9M | $1.3M | 26.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 52 | 1,148 | $1.0M | $257,899 | 24.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 416 | 1,524 | $722,376 | $160,067 | 22.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 703 | 982 | $418,700 | $96,732 | 23.1% |
| 92134 | Imaging of retina | Office | 2022 | 911 | 2,099 | $291,260 | $69,161 | 23.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 411 | 926 | $281,026 | $68,523 | 24.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 175 | 664 | $132,032 | $35,710 | 27.0% |
About Dr. George Ko, MD
Dr. George Ko, MD is a Ophthalmology healthcare provider based in Renton, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205890514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Ko, MD has received a total of $28,539 in payments from pharmaceutical and medical device companies, with $172.43 received in 2024. These payments were reported across 68 transactions from 23 companies. The most common payment nature is "Long term medical supply or device loan" ($24,381).
As a Medicare-enrolled provider, Ko has provided services to 17,957 Medicare beneficiaries, totaling 44,311 services with total Medicare billing of $8.2M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Renton, WA
- Active Since 04/13/2006
- Last Updated 07/10/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1205890514
Products in Payments
- VISUCAM Fundus Cameras (Device) $26,170
- Iluvien (Drug) $303.14
- ILUVIEN (Drug) $185.92
- CIRRUS HD-OCT (Device) $174.05
- VABYSMO (Drug) $141.50
- OZURDEX (Drug) $130.87
- ForeseeHome (Device) $113.19
- Lucentis (Biological) $79.08
- Vabysmo (Drug) $72.10
- EYLEA (Biological) $66.17
- ACTHAR (Biological) $56.33
- VISUDYNE (Drug) $47.99
- Jetrea (Drug) $46.14
- BROMSITE (Drug) $44.33
- YUTIQ (Drug) $40.82
- VYZULTA (Drug) $39.84
- INVELTYS (Drug) $35.48
- Izervay (Drug) $30.30
- PROKERA (Device) $23.35
- LUXTURNA (Biological) $23.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Renton
Dr. Joseph King, Md, MD
Ophthalmology — Payments: $29,221
Ophthalmology $29,221
Dr. Kenneth Fung, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $2,043
Ophthalmology $2,043
Silvia Mckevitt, Md, MD
Ophthalmology — Payments: $1,445
Ophthalmology $1,445
Mr. Jamison Ridgeley, Md, MD
Ophthalmology — Payments: $912.34
Ophthalmology $912.34
Dr. Samaneh Davoudimoghaddam, Md, MD
Ophthalmology — Payments: $745.90
Ophthalmology $745.90
Howard Straub, Do, DO
Ophthalmology — Payments: $729.71
Ophthalmology $729.71